Abstract
INTRODUCTION
The importance of inflammatory cytokines to the pathophysiology of heart failure (HF) has been recognized for many years [1] . Much of the focus has been on proin flammatory tumor necrosis factoralpha (TNFα) which has been shown to be cardiodepressant, contributes to exercise intolerance, and modulates apoptosis, oxidative stress and endothelial dysfunction [2, 3] .
Interleukin10 (IL10) antagonizes the inflammatory effects of TNFα. Both TNFα and IL10 plasma levels are elevated in HF patients, although the increase in IL10 is proportionately less, supporting the notion of a proinflammatory state [4] . Pro and antiinflammatory cytokine production is regulated by the adrenergic nervous system. Previous studies have demonstrated that β2, but not β1, receptor agonists attenuate TNFα expression, while increasing anti-inflammatory IL-10 production [5, 6] . Conversely, α1,2 adrenergic stimulation results in increased expression of TNFα and reduction in IL10 [7] . Under normal physiologic conditions, norepinephrine, an α and βagonist, reduces TNFα and enhances IL10 expression in monocytes exposed to lipopolysaccharide (LPS) and other stimuli [8] .
However, in HF a paradox exists as both catecholamines and TNFα are elevated, which suggests that this negative feedback mechanism may be impaired. The mechanism for the diminished immunomodulatory response to norepinephrine in HF is also unknown but could occur secondary to the altered adrenergic expression and function known to exist in the failing heart.
The study purpose was to evaluate whether attenu ation of TNFα production and augmentation of IL10 production by the adrenergic agonist norepinephrine is altered in chronic HF compared to healthy, agematched controls utilizing the model of LPSstimulated monocytes. In addition, preliminary experiments were undertaken to determine the relative contribution of α and βadrenergic receptor subtypes on the immunomodulatory activity of norepinephrine in monocytic THP1 cells.
MATERIALS AND METHODS

Isolated human monocytes
HF subjects were recruited from the cardiology clinics and the University Hospital at the University of Nebraska Medical Center. Subjects, male or female, were eligible for inclusion if they had: Clinical HF (LVEF < 40% on 2DECHO or MUGA within last 3 mo), New York Heart Association Functional Class (NYHA FC) IIIIV HF, and were over 30 years of age. Exclusion criteria included: Primary restrictive or valvular HF, acute viral illness or bacterial infection, history of autoimmune disease, concurrent therapy with systemic norepinephrine, known anemia (Hgb < 10 mg/dL) or other contraindication to giving blood. Healthy subjects over the age of 30 were recruited from the University of Nebraska Medical Center through a posting on the university Intranet. All human subjects gave informed consent for their participation. The protocol was approved by the Institutional Review Board of the university.
Monocyte isolation was performed following a standard Nycodenz protocol [9] , from 12 HF [age 66 ± 12 years old, New York Heart Association Functional Class (NYHA FC) 6 III, 6 IV, mean left ventricular ejection fraction 20% ± 10%] and 14 healthy subjects (age 66 ± 12 years). Aliquoted (1 x 10 6 /mL) monocytes were incubated with LPS 100 ng/mL, LPS + norepinephrine 10 6 mol/L or neither (negative control) for 4 h (all reagents from Sigma Chemical Co., Westbury, NY). Previous work demonstrated maximal stimulation of cytokines using the specified reagent concentrations and incubation time. TNFα and IL10 production were determined by assaying the supernatant using commercially available enzymelinked immunoassay (ELISA) kits (R and D Systems, Minneapolis, MN). TNFα and IL10 production was assessed as described above. Samples were assayed in duplicate.
THP-1 cells
Statistical analysis
To control for inherent intersubject differences in constitutive production of cytokines, changes in TNFα and IL10 concentrations are expressed as percent reduction by norepinephrine + LPS compared to LPS only for each sample. Comparison of percent reduction in TNFα and IL10 concentrations from isolated mono cytes of controls and HF subjects was performed by an independent two sample t test. Significance was set at P < 0.05. Results are reported as mean ± SD.
Comparative effects on cytokine production in THP1 cells between the different α and βadrenergic reagents was assessed via visual inspection of the doseresponse curves as this was a preliminary study. The statistical methods of this study were reviewed by Mimi Lou, MS (biostatistician) from the University of Southern California School of Pharmacy.
RESULTS
Isolated human monocytes
Study subject characteristics are described in Table 1 . Basal TNFα concentrations (supernatant) were higher in HF than healthy subjects (6.3 ± 3.3 pg/mL vs 2.5 ± 2.6 pg/mL, P = 0.004). Norepinephrine reduction of TNFα production was significantly reduced in monocytes from HF subjects (41% ± 17% HF vs 57% ± 9% healthy, P = 0.01). Norepinephrineinduced increases in monocyte IL10 production was also reduced in HF (16% ± 18% HF vs 38% ± 23% healthy, P = 0.012). The diminished response to norepinephrine appeared related to severity of HF, with a greater diminution for both TNFα and IL10 in NYHA FC IV vs NYHA FC III and controls (Figure 1) . A signal for reduced IL10 response in patients with left ventricular ejection fractions ≤ 20% when compared to those with left ventricular ejection fractions > 20% (7% ± 12 vs 25% ± 20%, P = 0.07) was also present. There were no differences in cytokine response based on the presence or absence of betablocker (BB) therapy (TNFα: 37% ± 17% no BB vs 46% ± 17% BB, P = 0.9; IL10: 11% ± 13% no BB vs 20% ± 22% BB, P = 0.3), or HF etiology (TNFα: 41% ± 17% ischemic vs 42% ± 18% nonischemic, P = 0.7; IL10: 20% ± 19% ischemic vs 8% ± 15% nonischemic, P = 0.5).
THP-1 cells
Norepinephrine and IPN, but not PE, induced a con centrationdependent suppression of TNFα production Ng TMH et al . Norepinephrine regulation of monocytes in HF severity, as indicated by the a greater diminution of the induced cytokine response in monocytes isolated from NYHA functional class IV as compared to functional class III patients and controls. This is the first report demonstrating monocyte TNFα/IL10 responsiveness to norepinephrine is diminished in HF and provides a novel mechanism to explain increased production of TNFα in HF. Our results are consistent with a study demonstrating a reduced inhibitory effect of norepinephrine on TNFα production assessed in whole blood of HF patients [10] . Our results also agree with other studies demonstrating basal monocytic inflammatory cytokine production is upregulated in chronic HF [11, 12] . In addition, based on our experiments in monocytic THP1 cells, norepinephrine's immunomodulatory effect in monocytes is likely secondary to activation of βadrenergic receptors, with no or little involvement of αadrenergic receptors. This was evidenced by the concentrationdependent reduction of TNFα and augmentation of IL10 production by norepinephrine and isoproterenol, but not by phenylephrine. The effect of norepinephrine could also be antagonized by βreceptor blockade with propranolol, whereas α1 and α2blocking agents had no effect. This is consistent with other 
DISCUSSION
Our preliminary findings suggest norepinephrine's ability to regulate monocyte inflammatory cytokine production may be reduced in moderate to severe HF. The ability of norepinephrine to exert an overall anti-inflammatory effect on the balance of production of TNFα and IL10 appears to be reduced in proportion to disease both catecholamines and TNFα are elevated, which suggests that this negative feedback mechanism may be impaired.
Research frontiers
HF is recognized as a proinflammatory syndrome, and that inflammatory pathways likely contribute to the decline in cardiac function. However, the mechanisms for initiation or persistence of the proinflammatory balance are poorly described and remain an area of active investigation. Clinical trials of agents targeting proinflammatory cytokines have failed to improve long term prognosis of HF patients. A major explanation for the failures is an incomplete understanding of mechanisms underlying the proinflammatory state.
Innovations and breakthroughs
Although it has been described that catecholamines reduce proinflammatory cytokine production, this is the first study to demonstrate that attenuation of monocyte inflammatory cytokine production by norepinephrine is reduced in cells isolated from HF patients compared to healthy individuals.
Applications
The findings are mainly descriptive but may represent a novel pathway for the proinflammatory state in patients with HF. If alterations in β-adrenergic receptor function is a mechanism for the diminished counter-regulatory response to norepinephrine in HF, some of the benefit of beta-adrenergic receptor blockers in HF may be due to immunomodulatory or anti-inflammatory effects. These preliminary findings need confirmation in future studies.
Peer-review
The manuscript is interesting because it adds new information concerning mechanisms underlying this proinflammatory state.
investigations and provides a plausible mechanism for the diminished cytokine response to norepinephrine observed in HF [1316] . Altered βadrenergic receptor function and expression have been well characterized in the failing heart [17, 18] . Beta1adrenergic receptor density and function is reduced in the failing heart, while beta 2adrenergic receptor expression remains essentially unchanged [19] . This shift in importance towards the beta 2adrenergic receptor would suggest immunomodulatory response to catecholamines would be preserved, however, other pathophysiologic alterations may still occur that change or limit their functionality [20, 21] . In addition, norepinephrine is known to have low affinity for beta2adrenergic receptors, but showed similar maximal effects comparable to isoproterenol [22, 23] . Therefore, whether the observed immunomodulatory response to norepinephrine is mediated solely through beta2 adrenergic receptors requires confirmation.
The study has important limitations. The human monocyte experiment sample size is small. Unfortunately we did not have an adequate number of human mono cytes to evaluate adrenoreceptor expression between HF and healthy subjects which would strengthen these preliminary findings as THP1 are a monocytic cell line but may not be identical to human monocytes. We also did not examine the isolated effects of the receptor antagonists propranolol, yohimbine and prazosin as we are not aware of literature suggesting a direct effect on inflammatory cytokine production, only modulation in a proinflammatory model [6, 7, 13, 14, 2427] . As such, the results of this study are preliminary and should be interpreted as hypothesis generating. Further studies are required to determine whether monocyte production of other cytokines exhibit a similar reduction in response to catecholamine stimulation in HF, to fully characterize the mechanism for the observed impaired catecholamine cytokine response, and to devise pharmacologic strategies to normalize cytokine responsiveness to the adrenergic nervous system.
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Background
Inflammation has been recognized as a major contributing factor to the pathophysiology of heart failure (HF) with reduced ejection fraction (HFrEF) for many years. However, attempts to improve the prognosis of HFrEF patients by targeting proinflammatory cytokines have failed largely in part to an incomplete understanding of the mechanisms which contribute to the initiation and perpetuation of their expression. Pro-and anti-inflammatory cytokine production is regulated by the adrenergic nervous system. Under normal physiologic conditions, norepinephrine, an α-and β-agonist, reduces tumor necrosis factoralpha (TNFα) and enhances interleukin-10 expression in monocytes exposed to lipopolysaccharide and other stimuli. However, in HFrEF a paradox exists as
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